ADTX - Aditxt signs agreement to acquire Appili Therapeutics
2024-04-02 08:51:10 ET
More on Aditx Therapeutics, Appili Therapeutics, etc.
- Evofem Biosciences achieves 2023 prelim net product sales of $18.1M to $18.3M
- Aditxt buys Brain Scientific's portfolio of EEG brain monitoring technologies and devices
- Financial information for Aditx Therapeutics
- Seeking Alpha’s Quant Rating on Appili Therapeutics
- Historical earnings data for Appili Therapeutics